title: Rituximab therapy for refractory immune thrombocytopenic purpura in elder patients.
authors.forename: Akira
authors.initials: A
authors.lastname: Hangaishi
authors.forename: Tsuyoshi
authors.initials: T
authors.lastname: Takahashi
authors.forename: Akiko
authors.initials: A
authors.lastname: Masuda
authors.forename: Sumitaka
authors.initials: S
authors.lastname: Okada
authors.forename: Koji
authors.initials: K
authors.lastname: Kandabashi
authors.forename: Mineo
authors.initials: M
authors.lastname: Kurokawa
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D008297:Male; D010976:Platelet Count; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy*; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab